ARUP Laboratories Announces New CEO and President

ARUP Laboratories
August 11, 2017

ARUP Laboratories announced a new chief executive officer (CEO) and president. Sherrie Perkins, MD, PhD, accepted the role of CEO and Andrew Theurer accepted the position of president. Together, they bring more than 50 years of combined ARUP experience to the helm. 

“Together, we’re looking forward to meeting the challenges ahead and are excited to continue providing excellent patient care and cutting-edge laboratory medicine,” says Perkins, who is an internationally recognized pathologist with a long history of leadership at ARUP and the Department of Pathology.  “For more than 25 years, I’ve been a part of this company, and during that time I’ve become deeply committed to the people and company mission that have made ARUP what it is today.”   

Perkins has been serving as senior vice president of research and development at ARUP, as well as professor, vice-chair, and division chief of Clinical Pathology. She has previously served as chief medical officer and director of laboratories at ARUP, and interim chair of the Department of Pathology, among other important roles. She is a tenured professor at the University of Utah School of Medicine.

Andy Theurer, President

Andy Theurer
President

Sherrie Perkins, MD, PhD, CEO

Sherrie Perkins, MD, PhD
CEO

“I’ve seen ARUP grow to become one the country’s largest and most respected national-reference laboratories, and I am incredibly proud to be a part of its leadership,” says Theurer. He has been serving as senior vice president and chief financial officer at ARUP and has deep expertise in the laboratory industry, as well as extensive experience with all aspects related to ARUP’s business enterprise. Theurer has played a key role in formulating and implementing ARUP’s highly successful business strategy, and is committed to supporting academics and fostering strong productive relationships within our university community.

They will be replacing Edgar Braendle, MD, PhD, who has served as CEO and President of ARUP Laboratories for the past year. Dr. Braendle has decided to step down in order to pursue new opportunities and rejoin his family in New Jersey. 

Some 50,000 patient specimens are processed daily at ARUP, linked to the lives of thousands of patients. The expertise and dedication of ARUP’s 3,500 employees and its academic-medical collaborations with the University of Utah have made ARUP one of the country’s leading and largest laboratories in the nation. Perkins and Theurer are committed to making sure ARUP continues on this impressive path of success. 

Peta Owens-Liston, Science Communications Writer
Share this article: